You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盤龍藥業(002864.SZ):擬向嘉華天然氣採購不超112.5萬元天然氣 向歐珂藥業供應22.12萬元中藥材
格隆匯 12-12 17:54

格隆匯12月12日丨盤龍藥業(002864.SZ)公佈,公司向柞水嘉華天然氣有限公司(“嘉華天然氣”)採購天然氣,總金額不超過112.50萬元。嘉華天然氣董事長張淑雲系公司董事長謝曉林配偶,故此次交易構成關聯交易。

公司全資子公司陝西商洛盤龍植物藥業有限公司(“植物藥業”)向陝西歐珂藥業有限公司(“歐珂藥業”)供應中藥材,總金額為22.12萬元。歐珂藥業總經理謝曉鋒系公司董事,故此次交易構成關聯交易。

1.嘉華天然氣《供用氣合同》主要內容:

甲方:陝西盤龍藥業集團股份有限公司;乙方:柞水嘉華天然氣有限公司

乙方同意,除非出現合同約定的乙方停氣、短氣、降壓等情形外,向甲方全天24小時連續供應天然氣,預計用氣量為25萬方。用氣的價格、結算方式為:用氣的價格:4.5元/立方米氣費結算方式:甲乙雙方採用IC卡預購售氣形式。

2.歐珂藥業《中藥材採購合同》主要內容 :

甲方:陝西歐珂藥業有限公司;乙方:陝西商洛盤龍植物藥業有限公司

甲方向乙方採購中藥材白蘞、木香、北柴胡、薄荷、薄荷、花椒、蟬蜕以及地黃,共計22.123萬元。

公司生產基地位於柞水縣內,而嘉華天然氣為柞水縣獨家天然氣供應商,公司向嘉華天然氣採購天然氣係為滿足公司日常生產經營需要,採購價格根據市場價格確定,價格公允、合理,此次關聯交易不會對公司的財務狀況、日常經常產生影響,不存在損害公司和股東利益的情形。

歐珂藥業為生產經營需要向植物藥業採購中藥材,定價根據市場價格確定,價格公允、合理,此次關聯交易不會對公司的財務狀況、日常經常產生影響,不存在損害公司和股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account